Wednesday, February 10, 2010, 7:32pm SGT - The Singapore stock market is closed.
To create a watchlist or portfolio of shares, Register
FINANCE HOME PAGEINVESTINGFINANCE NEWS
    Market:       |  

CombinatoRx, Incorporated (CRXX)

At 5:00AM SGT: 1.18 USD   0.00 (0.00%)  
 MORE ON CRXX 
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
 CombinatoRx, Incorporated (NGM:CRXX) Delayed quote dataEdit
Last Trade:1.18 USD
Trade Time:5:00AM SGT
Change: 0.00 (0.00%)
Prev Close:1.18
Open:N/A
Bid:0.91 x 200
Ask:2.94 x 200
1y Target Est:1.00
Day's Range:N/A - N/A
52wk Range:0.41 - 2.60
Volume:0
Avg Vol (3m):1,221,740
Market Cap:41.31M
P/E (ttm):N/A
EPS (ttm):-0.72
Div & Yield:N/A (N/A%)
[Chart]
1d  5d  3m  6m  1y  2y  5y 
Use Y! Toolbar to track stocks
 Add CRXX to Portfolio   Download Data

 HEADLINES 
•Biopharmaceutical Stock Alert for CombinatoRx Inc. Issued by InvestorSoup
GlobeNewswire (Thu, Jan 28)
•Stephen Simpson Of Northland Securities Picks 4 Health Care Stock Winners For 2010
Wall Street Transcript (Thu, Jan 28)
•CombinatoRx dangles incentives for new CEO
at bizjournals.com (Thu, Jan 21)
•COMBINATORX, INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits
EDGAR Online (Wed, Jan 20)
•Emerging Stock Report Initiates Independent Research Coverage on CombinatoRx, Incorporated
GlobeNewswire (Thu, Jan 14)
•CombinatoRx reassigns new CEO, COO steps down
at bizjournals.com (Thu, Jan 7)
•CombinatoRx Announces Senior Management Team Changes
Business Wire (Wed, Jan 6)
•COMBINATORX, INC Files SEC form 8-K, Other Events
EDGAR Online (Tue, Jan 5)
•COMBINATORX, INC Files SEC form 8-K/A, Completion of Acquisition or Disposition of Assets, Material Modification to R
EDGAR Online (Wed, Dec 23)
•CombinatoRx closes deal with Neuromed
at bizjournals.com (Wed, Dec 23)
More Headlines for CRXX...
 ANALYST 
EPS Est (next year) (Dec-09) :N/A
EPS Est (in 2 years) (Dec-10) :N/A
Avg Rec (current)*:3.0
PEG Ratio:N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

 BUSINESS SUMMARY 
CombinatoRx, Incorporated, a biopharmaceutical company, focuses on discovering, developing, and outlicensing synergistic combination pharmaceuticals. It develops novel therapeutics with multi-target mechanisms of action that are built from combina...

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Search by Company
•Latest News•Singapore Indices